PharmX Technologies Limited (ASX:PHX)
Australia
· Delayed Price · Currency is AUD 0.105
-0.005 (-4.55%)
Mar 10, 2026, 10:52 AM AEST
PharmX Technologies Revenue
PharmX Technologies had revenue of 3.89M AUD in the half year ending December 31, 2025, with 20.25% growth. This brings the company's revenue in the last twelve months to 7.65M, down -11.41% year-over-year. In the fiscal year ending June 30, 2025, PharmX Technologies had annual revenue of 7.53M, down -6.97%.
Revenue (ttm)
7.65M
Revenue Growth
-11.41%
P/S Ratio
9.49
Revenue / Employee
70.16K
Employees
109
Market Cap
72.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 7.53M | -564.00K | -6.97% |
| Jun 30, 2024 | 8.09M | 1.97M | 32.10% |
| Jun 30, 2023 | 6.13M | 742.00K | 13.78% |
| Jun 30, 2022 | 5.39M | -6.49M | -54.65% |
| Jun 30, 2021 | 11.88M | 1.23M | 11.58% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mach7 Technologies | 29.69M |
| Singular Health Group | 961.53K |
| BlinkLab | 375.82K |
| Beamtree Holdings | 28.90M |
| Alcidion Group | 48.62M |
| Vitasora Health | 5.01M |
| Emyria | 2.29M |
| PainChek | 3.44M |